Zevra Therapeutics Inc. Common Stock
ZVRAUnited States
5 filed reports · 311 financial concepts · 4 earnings calls · 0 media appearances
Filed reports
5 reports · Jun 2025 to Jun 2026Each report counts once it has at least one extracted financial fact.
| Report type | Reports | Facts | Periods |
|---|---|---|---|
| Quarterly · 10-QSEC EDGAR | 4 | 1,110 | Jun 2025 to Jun 2026 |
| Annual · 10-KSEC EDGAR | 1 | 749 | Dec 2025 |
Financial data
311 concepts · 1,859 factsEach concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.
Financial302 concepts · 1,754 facts · Jun 2021 to Jun 2026
- Adjustments to additional paid in capital sharebased compensation requisite service period recognition value12 · Mar 2024 to Jun 2026
- Current portion of discount and rebate liabilities12 · Dec 2024 to Jun 2026
- Discount and rebate liabilities, less current portion12 · Dec 2024 to Jun 2026
- Net income loss12 · Mar 2024 to Jun 2026
- Other comprehensive income loss net of tax portion attributable to parent12 · Mar 2024 to Jun 2026
- Stockholders equity (US GAAP)12 · Mar 2024 to Jun 2026
- Warrant liability12 · Dec 2024 to Jun 2026
- Allocated share based compensation expense11 · Jun 2024 to Jun 2026
- Amortization of intangible assets11 · Jun 2024 to Jun 2026
- Cash cash equivalents restricted cash and restricted cash equivalents including disposal group and discontinued operations11 · Jun 2024 to Jun 2026
- Comprehensive income net of tax11 · Jun 2024 to Jun 2026
- Cost of goods and service excluding depreciation depletion and amortization11 · Jun 2024 to Jun 2026
- Costs and expenses11 · Jun 2024 to Jun 2026
- Fair value adjustment related to investments11 · Jun 2024 to Jun 2026
- Fair value adjustment related to warrant and CVR liability11 · Jun 2024 to Jun 2026
- Gain loss on disposition of intangible assets11 · Jun 2024 to Jun 2026
- Impairment of intangible assets finitelived11 · Jun 2024 to Jun 2026
- Income tax expense benefit11 · Jun 2024 to Jun 2026
- Interest and other income, net11 · Jun 2024 to Jun 2026
- Interest expense nonoperating11 · Jun 2024 to Jun 2026
- Inventory write down11 · Jun 2024 to Jun 2026
- Lease cost11 · Jun 2024 to Jun 2026
- Nonoperating income expense11 · Jun 2024 to Jun 2026
- Operating income loss11 · Jun 2024 to Jun 2026
Segment8 concepts · 86 facts · Jun 2024 to Jun 2026
- Depreciation depletion and amortization11 · Jun 2024 to Jun 2026
- Income tax expense benefit11 · Jun 2024 to Jun 2026
- Interest expense nonoperating11 · Jun 2024 to Jun 2026
- Investment income interest11 · Jun 2024 to Jun 2026
- Net income loss11 · Jun 2024 to Jun 2026
- Other nonoperating income expense11 · Jun 2024 to Jun 2026
- Revenue11 · Jun 2024 to Jun 2026
- Impairment of intangible assets finitelived9 · Jun 2024 to Jun 2026
Product1 concepts · 19 facts · Jun 2024 to Jun 2026
- Revenue19 · Jun 2024 to Jun 2026
Segments
105 factsFigures broken down by business line, region, product or another axis the company reports on.
Statement business segments1 member · 86 facts
- Reportable86 · Jun 2024 to Jun 2026
Product or service4 members · 19 facts
- MIPLYFFA8 · Dec 2024 to Jun 2026
- OLPRUVA7 · Jun 2024 to Jun 2026
- License2 · Jun 2025 to Sep 2025
- Olpruva2 · Dec 2024 to Dec 2025
Text from filings
Management commentary and risk factors, extracted from SEC filings only.
No commentary or risk-factor text for this company.
Earnings calls
4 calls · Aug 2025 to May 2026Transcripts with management claims and analyst questions, one per fiscal period.
- FY2026 Q1May 6, 2026
- FY2025 Q4Mar 9, 2026
- FY2025 Q3Nov 5, 2025
- FY2025 Q2Aug 12, 2025
Executive media
Podcasts, interviews and conference appearances by the company's executives, with their claims.
No media appearances for this company.
Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 16, 2026) and refreshed every few hours.